HomeNYSE:GSK

NYSE:GSK

GSK Ups Forecast Following Strong Q2 Performance

GSK Ups Forecast Following Strong Q2 Performance

July 31, 2024

GSK Stock Fell After 40 Years of Silence Regarding Zantac’s Cancer Dangers, Bloomberg

GSK Stock Fell After 40 Years of Silence Regarding Zantac’s Cancer Dangers, Bloomberg

February 16, 2023

GSK Stock Fell after Bank of America Downgraded It to Underperform

GSK Stock Fell after Bank of America Downgraded It to Underperform

December 5, 2022

GSK announces an upcoming FDA AdCom conference on the treatment of renal disease

GSK announces an upcoming FDA AdCom conference on the treatment of renal disease

September 6, 2022

Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines

August 29, 2022